Key result
Elevated IL-6 and hsCRP linked to increased poststroke recurrence regardless of atherosclerosis status.
Why the study?
Are elevated IL-6 and hsCRP associated with recurrent stroke or MACE in patients with ischemic stroke/TIA, irrespective of atherosclerosis status?
Meta-Analysis
Yes
Are elevated IL-6 and hsCRP associated with recurrent stroke or MACE in patients with ischemic stroke/TIA, irrespective of atherosclerosis status?
Answers are grounded in this paper and cite their sources.
Elevated inflammatory markers (IL-6 and hsCRP) are associated with vascular recurrence after stroke regardless of baseline atherosclerosis status, supporting the potential role of anti-inflammatory therapies in a broader stroke population.
BACKGROUND: Uncertainty remains whether inflammation is implicated in poststroke recurrence in patients without atherosclerosis. We evaluated the contribution of atherosclerosis status to the association between inflammatory markers and major adverse cardiovascular events (MACE) poststroke. METHODS: We performed an individual-participant data meta-analysis of 11 prospective cohorts (12 countries, 1995-2017). Studies included patients with ischemic stroke/transient ischemic attack and measured IL (interleukin)-6/hsCRP (high-sensitivity C-reactive protein) postevent. We analyzed the association between IL-6/hsCRP and recurrent stroke/MACE using multivariable Cox regression analyses (conditional logistic regression for 1 study). Analyses were stratified by the presence/absence of atherosclerosis (definition: prior history of coronary disease, peripheral artery disease, or large artery atherosclerotic stroke) and adjusted for cardiovascular risk factors/preventative medication. CONCLUSIONS: IL-6/hsCRP were associated with poststroke recurrence irrespective of atherosclerosis. These data support the inclusion of patients in trials of anti-inflammatory therapies after stroke with elevated IL-6 or hsCRP, including those without prior atherosclerotic events.
No takes yet. Share an insight, caveat, or question.
McCabe et al. (2025) conducted a meta-analysis in ischemic stroke/transient ischemic attack. IL-6 and hsCRP was evaluated on recurrent stroke/MACE (p==0.18). Elevated IL-6 and hsCRP were associated with poststroke recurrence irrespective of atherosclerosis status.
Synapse has enriched 10 related papers. Consider them for comparative context: